TrialMedical oncology (Northwood, London, England)2018

A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer.

Kei Saito et al.PubMed ↗Publisher ↗

No numbers read from the abstract.